GlassScriptPhysician profile
Melissa Gonzalez
NPI 1396286597
$5,482.07
in general payments reported to CMS, 2019-2025
37 companies · $2,504 in 2025
The $2,504 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $366 · 2021: $246 · 2022: $154 · 2023: $827 · 2024: $1,385 · 2025: $2,504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,715.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $901.93 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $555.51 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $551.85 | 2022-2025 | |
| Amgen INC. | $486.87 | 2023-2025 | Repatha, Repatha, Otezla |
| Exact Sciences Corporation | $437.77 | 2023-2025 | Cologuard Collection Kit |
| Corcept Therapeutics | $300.58 | 2024-2025 | Korlym |
| Glaxosmithkline, LLC. | $298.81 | 2020-2025 | Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $286.21 | 2020-2025 | Mounjaro, Zepbound, Reyvow |
| Insulet Corporation | $267.27 | 2025 | Omnipod, Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $255.60 | 2022-2025 | |
| Pfizer INC. | $122.49 | 2023-2025 | |
| Abbott Laboratories | $118.27 | 2021-2025 | Freestyle Libre 3, Proclaim |
| Amarin Pharma, INC. | $109.86 | 2020-2021 | |
| Astellas Pharma US INC | $82.93 | 2020-2025 | Veozah |
| Kowa Pharmaceuticals America, INC. | $77.19 | 2023-2025 | Zoryve, Livalo, Seglentis |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.